|
2024
|
Invention
|
Compound having akt kinase-degrading activity, preparation method therefor, and pharmaceutical us... |
|
|
Invention
|
Use of akt inhibitor in preparation of drug for preventing or treating ovarian cancer. Use of an ... |
|
|
Invention
|
Use of akt inhibitor in preparation of drug for preventing or treating breast cancer. Disclosed i... |
|
|
Invention
|
Crystal form of methionine adenosyltransferase 2a heterocyclic inhibitor, preparation method ther... |
|
|
Invention
|
Salt and crystal form of methionine adenosyltransferase-2a heterocyclic inhibitor, and preparatio... |
|
|
Invention
|
Substituted pyrazine compound having axl inhibitory activity. The present invention relates to a ... |
|
|
Invention
|
Anti-igf1r antibodies and uses thereof. Provided are anti-IGF1R (insulin-like growth factor 1 rec... |
|
|
Invention
|
Preparation method for axl inhibitor intermediate. The present invention relates to the field of ... |
|
|
Invention
|
Method for preparing axl inhibitor. The present invention provides a method for preparing an AXL ... |
|
|
Invention
|
Inhibitor of complement factor b. Provided in the present disclosure is an inhibitor of the compl... |
|
|
Invention
|
Dihydropyrido[2,3-d]pyrimidinone derivative, preparation method therefor and medical use thereof.... |
|
2023
|
Invention
|
Pharmaceutical composition acting as axl inhibitor. Disclosed in the present invention is a pharm... |
|
|
Invention
|
Substituted triazole compound having axl inhibitory activity. Disclosed is a substituted triazole... |
|
2022
|
Invention
|
Methionine adenosyltransferase 2a heterocyclic inhibitor.
Disclosed is a methionine adenosyltran... |
|
|
Invention
|
Methionine adenosyltransferase 2a heterocyclic inhibitor. Disclosed is a methionine adenosyltrans... |
|
|
Invention
|
Mono-p-toluenesulfonate of axl kinase inhibitor and crystal form thereof.
The present invention ... |
|
|
Invention
|
Mono-p-toluenesulfonate of axl kinase inhibitor and crystal form thereof. The present invention p... |
|
|
Invention
|
Salt of axl kinase inhibitor, preparation method therefor and use thereof. The present invention ... |
|
|
Invention
|
Benzocycloheptane compound as axl inhibitor. A benzocycloheptane compound as an AXL inhibitor and... |
|
|
Invention
|
1,2,4-triazole compounds as axl inhibitors. The present invention relates to 1,2,4-triazole compo... |
|
|
Invention
|
Methionine adenosyltransferase 2a inhibitor.
The present invention provides a methionine adenosy... |
|
|
Invention
|
Methionine adenosyltransferase 2a inhibitor. The present invention provides a methionine adenosyl... |
|
2021
|
Invention
|
Pyrazoloazepine akt inhibitor. Disclosed in the present invention is a pyrazoloazepine compound i... |
|
|
Invention
|
Unit dosage composition of akt inhibitor.
A unit dosage composition of an AKT inhibitor, and in ... |
|
|
Invention
|
Salt of dihydropyrido[2,3-d]pyrimidinone derivative, preparation method therefor, and use thereof... |
|
|
Invention
|
Salt and crystal form of dihydropyrido[2,3-d]pyrimidine derivate.
A salt and crystal form of a d... |
|
|
Invention
|
Unit dosage composition of akt inhibitor. The present application provides a unit dosage composit... |
|
|
Invention
|
Salt and crystal form of dihydropyrido[2,3-d]pyrimidine derivate. Disclosed in the present applic... |
|
|
G/S
|
Medicines for human purposes; injection (term considered too
vague by the International Bureau -... |
|
|
Invention
|
Pyrimidine compound as axl inhibitor.
A pyrimidine compound as an AXL inhibitor is provided. The... |
|
|
Invention
|
Pyrimidine compound as axl inhibitor. Disclosed in the present invention is a pyrimidine compound... |
|
|
Invention
|
Deuterated akt kinase inhibitor. The present invention relates to a deuterated AKT kinase inhibit... |
|
2020
|
Invention
|
Quinazoline compound used as axl inhibitor. Disclosed is a quinazoline compound used as an AXL in... |
|
|
Invention
|
Method for preparing highly stereoselective β-glycoside compound. Provided is a method for prepar... |
|
|
Invention
|
Preparation method for phosphamide compound used for synthesizing chiral drug. 33 aqueous solutio... |
|
|
Invention
|
Novel non-hygroscopic low-variability crystalline form for treatment of hepatitis c. A novel non-... |
|
|
Invention
|
Akt inhibitor.
The present invention discloses an AKT inhibitor, and specifically relates to a c... |
|
|
Invention
|
Akt inhibitor. The present invention discloses an AKT inhibitor, and specifically relates to a co... |
|
2019
|
Invention
|
Anticoagulant pentasaccharide compound, composition, and preparation method and medical use there... |
|
|
Invention
|
Preparation method for 4-idarubicin hydrochloride. Provided is a method for preparing 4-idarubici... |
|
|
Invention
|
Analysis method for determining substance related to lubiprostone test sample. Provided is an ana... |
|
2018
|
Invention
|
Crystal form of idarubicin hydrochloride monohydrate. Disclosed in the present invention are a no... |
|
2010
|
Invention
|
Crystals of prasugrel hydrobromate. The crystals of 2-acetoxy-5-(α-cyclopropylcarbonyl-2-fluorobe... |
